Topiramate for the treatment of methamphetamine addiction: A multi-center placebo-controlled trial

Addiction

Volumn 107, Issue 7, 2012, Pages 1297-1306

  Elkashef, Ahmed ^a   Kahn, Roberta ^a   Yu, Elmer ^b   Iturriaga, Erin ^a   Li, Shou Hua ^a   Anderson, Ann ^a   Chiang, Nora ^a   Ait Daoud, Nassima ^c   Weiss, David ^d   Mcsherry, Frances ^d   Serpi, Tracey ^d   Rawson, Richard ^e   Hrymoc, Mark ^e   Weis, Dennis ^f   Mccann, Michael ^g   Pham, Tony ^g   Stock, Christopher ^d   Dickinson, Ruth ^d   Campbell, Jan ^h   Gorodetzky, Charles ^h   Haning, William ⁱ   Carlton, Barry ⁱ   Mawhinney, Joseph ^j   Li, Ming D ^c   Johnson, Bankole A ^c   more..

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Lutheran Hospital Office of Research   (United States)

^g Matrix Institute on Addictions   (United States)

^h UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

ⁱ Pacific Addiction Research Center   (United States)

^j South Bay Treatment Center   (United States)

more..

Author keywords

Abstinence facilitation; Methamphetamine abuse; Topiramate; Treatment

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; FRUCTOSE; GABAERGIC RECEPTOR AFFECTING AGENT; METHAMPHETAMINE; TOPIRAMATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATIENT COMPLIANCE; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AMPHETAMINE-RELATED DISORDERS; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FRUCTOSE; GABA AGENTS; HUMANS; MALE; MEDICATION ADHERENCE; METHAMPHETAMINE; MIDDLE AGED; PSYCHOMETRICS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862777632     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03771.x     Document Type: Article

References (20)

1. Johnson B. A., Ait-Daoud N., Bowden C. L., DiClemente C. C., Roache J. D., Lawson K. etal. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 2003; 361: 1677-85.
2. Johnson B. A., Rosenthal N., Capece J. A., Wiegand F., Mao L., Beyers K. etal. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 2007; 298: 1641-51.
3. Kampman K. M., Pettinati H., Lynch K. G., Dackis C., Sparkman T., Weigley C. etal. A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 2004; 75: 233-40.
4. Kushner S. A., Dewey S. L., Kornetsky C. The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats. J Pharmacol Exp Ther 1999; 290: 797-802.
5. Gryder D. S., Rogawski M. A. Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci 2003; 23: 7069-74.
6. McFarland K., Lapish C. C., Kalivas P. W. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 2003; 23: 3531-7.
7. García Campayo J., Sobradiel N., Alda M., Mas A., Andrés E., Magallón R. etal. Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial. BMC Fam Pract 2008; 9: 28.
8. Leombruni P., Lavagnino L., Fassino S. Treatment of obese patients with binge eating disorder using topiramate: a review. Neuropsychiatr Dis Treat 2009; 5: 385-92.
9. Tatsuta T., Kitanaka N., Kitanaka J., Morita Y., Takemura M. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice. Pharmacol Biochem Behav 2007; 87: 48-55.
10. Akhondzadeh S., Hampa A. D. Topiramate prevents ecstasy consumption: a case report. Fundam Clin Pharmacol 2005; 19: 601-2.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association; 1994.
12. First M. B., Spitzer R. L., Gibbon M., Williams J. B. W. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0). New York: New York State Psychiatric Institute, Biometrics Research Department; 1994.
13. Montgomery S. A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-9.
14. Johnson B. A., DiClemente C. C., Ait-Daoud N., Stoks S. M. Brief Behavioral Compliance Enhancement Treatment (BBCET) manual. In: Johnson B. A., Ruiz P., Galanter M., editors. Handbook of Clinical Alcoholism Treatment. Baltimore, MD: Lippincott Williams & Wilkins; 2003, p. 282-301.
15. Kampman K. M., Volpicelli J. R., Mulvaney F., Rukstalis M., Alterman A. I., Pettinati H. etal. Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addict Behav 2002; 27: 251-60.
16. Johnson B. A., Wells L. T., Roache J. D., Wallace C. L., Ait-Daoud N., Dawes M. A. etal. Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 455-61.
17. Johnson B. A., Ait-Daoud N., Elkashef A. M., Smith E. V., Kahn R., Vocci F. etal. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence. Int J Neuropsychopharmacol 2008; 11: 1-14.
18. Shearer J., Darke S., Rodgers C., Slade T., van Beek I., Lewis J. etal. A double-blind, placebo-controlled trial of modafinil (200mg/day) for methamphetamine dependence. Addiction 2009; 104: 224-33.
19. Elkashef A. M., Rawson R. A., Anderson A. L., Li S. H., Holmes T., Smith E. V. etal. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology 2008; 33: 1162-70.
20. Davis J. M., Kopin I. J., Lemberger L., Axelrod J. Effects of urinary pH on amphetamine metabolism. Ann NY Acad Sci 1971; 179: 493-501.